We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Events

08 Dec 2026 - 10 Dec 2026
25 Jan 2027 - 28 Jan 2027

Microneedle Patch Enables At-Home Monitoring of Acute Kidney Injury

By HospiMedica International staff writers
Posted on 27 Aug 2026

Kidney disease is often silent in its early stages, making timely detection difficult outside clinical settings. More...

Early biomarkers such as neutrophil gelatinase–associated lipocalin can require blood draws and refrigerated handling, which limits home or point‑of‑care use. Simpler, minimally invasive testing could expand access to earlier diagnosis and monitoring. To help address this challenge, researchers have developed a painless microneedle skin patch that captures kidney injury biomarkers.

Engineers at the McKelvey School of Engineering at Washington University in St. Louis, working with Washington University School of Medicine and Texas A&M University, created a patch designed for quick, safe sampling from the skin. The device aims to support earlier identification of kidney injury and to enable monitoring outside traditional laboratories. The approach focuses on stable, on‑skin biomarker capture to simplify logistics and expand access.

The technology uses microneedles coated with a metal‑organic framework (MOF) to sample interstitial fluid. The MOF forms a protective shell that both detects and preserves antibodies targeting neutrophil gelatinase–associated lipocalin (NGAL), an early, clinically validated biomarker of acute kidney injury. The patch captured biomarkers for accurate quantification and maintained antibody function for up to four weeks at 50°C without refrigeration, supporting potential use in home or resource‑limited settings.

Findings were published in Advanced Materials on August 5, 2026. According to the team, this is the first demonstration that encapsulating biomolecules on microneedles can preserve their biological functions. The work builds on earlier microneedle patches and adapts the platform to achieve higher sensitivity and a broader dynamic range while addressing cold‑chain constraints that limit current NGAL testing. NGAL rises in blood within hours of kidney injury, but dependence on phlebotomy and refrigerated logistics has impeded its use for at‑home or remote monitoring.

“This metal-organic framework encapsulation is a simple and highly effective way to create microneedle sensors that are resilient to environmental challenges and provide a scalable path to minimally invasive biosensing for at-home or remote health monitoring,” said Srikanth Singamaneni, Lilyan & E. Lisle Hughes Professor in the Department of Mechanical Engineering & Materials Science at Washington University in St. Louis.

Related Links
Washington University in St. Louis


Gold Member
Neonatal Heel Incision Device
Tenderfoot
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Glucose Meter
StatStrip®
Radiofrequency Generator
GX1
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image Credit: Shutterstock

Explainable AI Examines Sepsis Mortality Risk and Emergency Care Delays

Preventing sepsis-related deaths in emergency departments (EDs) remains challenging because patient deterioration can result from multiple rapidly evolving and interconnected factors. These include triage... Read more

Patient Care

view channel
Image: A view inside the custom virtual reality environment used in the study: a calm room with a teddy bear, soft colors and large windows looking out over the sea. (Image Credit: Walaa S. Abu Rukbah et al., Virginia Commonwealth University; CC-BY 4.0, https://creativecommons.org/licenses/by/4.0/)

Virtual Reality Program May Reduce Anxiety Before Pediatric Surgery

Presurgery anxiety affects an estimated 50% to 75% of children undergoing surgery and can complicate anesthesia induction, increase postoperative pain, and prolong recovery. Sedation is often used to manage... Read more

Medical Imaging

view channel
Image: A new automated approach could help predict which patients with dystonia will benefit from deep brain stimulation before surgery (Image Credit: Adobe Stock)

AI Uses Routine MRI to Predict Deep Brain Stimulation Response in Dystonia

Dystonia is a debilitating neurological movement disorder characterized by involuntary muscle contractions that cause abnormal movements and postures. Deep brain stimulation (DBS) is one of the few treatments... Read more

Health IT

view channel
Image Credit: Shutterstock

Telemonitoring Program Improves Quality of Life After Heart Failure Discharge

Heart failure is a chronic condition associated with high mortality, frequent hospitalizations, and reduced quality of life. Patients face particularly high risks of readmission and death after discharge,... Read more

Business

view channel
Image: Stryker has acquired ZuriMED, adding the FiberLocker System, a rotator cuff augmentation technology designed to strengthen repairs, to its Sports Medicine portfolio. (Photo courtesy of ZuriMED)

Stryker Completes Acquisition to Broaden Shoulder Surgery Offerings

Stryker (Portage, MI, USA) has completed its acquisition of ZuriMED (Zurich, Switzerland), a privately held developer of the FiberLocker System, expanding its Sports Medicine portfolio with a commercialized... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.